Therapeutic effects of telmisartan and irbesartan on hypertensive patients with overt diabetic nephropathy

Trial Profile

Therapeutic effects of telmisartan and irbesartan on hypertensive patients with overt diabetic nephropathy

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 22 Sep 2015

At a glance

  • Drugs Irbesartan (Primary) ; Telmisartan (Primary)
  • Indications Hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Sep 2015 Status changed from recruiting to discontinued as reported by University Hospital Medical Information Network - Japan.
    • 03 Nov 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top